Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity.
$9.58 -0.76 (-7.35%)
As of 03/24/2023 15:59:45 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.